$6135.T Makino hasn’t announced a stock buyback yet because it is still officially in play. NSSK made a non-binding, preliminary acquisition proposal for Makino in April without details. The board is evaluating the proposal and won’t buy back shares in the meantime.
I don’t think this deal will go through.
Unlike MBK Partners, NSSK should clear regulatory hurdles as a Japanese private equity investor. But I don't see it as an obviously superior long-term Makino owner. NSSK has historically focused on healthcare, education, retail, leisure, general manufacturing, and other mid-market businesses. These are very different investments from the world-class machine tools franchise with sensitive defense technologies.
Furthermore, Makino’s share price has increased to ~¥15,000 (market cap ¥350b ex treasury shares) since MBK’s ¥11,751 offer, so NSSK needs to propose a meaningfully higher price today. NSSK’s IV Series Funds closed at ¥250b in March. Given this, a complete Makino buyout will be impossible to pull off without serious financial backing from a local equity consortium and Japanese banks. Getting so many (conservative) parties on board to bid around ¥18,000-20,000 won't be easy.
I believe the most likely outcome is that Makino stays an independent, publicly listed entity. This will be the best result for shareholders in the long run. Management now has a credible medium-term plan focused on the right levers. I count on it to expand margins, increase working capital turnover, and reduce lead times, boosting free cash flow. I assume Makino will generate ¥25-30b FCF annually in the next two-three years, creating significant room for shareholder returns.
After digging around, I finally settled on my favorite Japanese machine tool producer: Makino $6135.T From giga-casting molds and satellite structures to gas turbine cooling holes and vascular stents, Makino’s tools excel in the toughest machining jobs.
The failed Nidec acquisition in 2025 and the blocked PE buyout in April revealed the company’s strategic value. The Japanese government blocked MBK Partners’ acquisition of Makino on national security grounds, arguing that its machines “are widely utilized by manufacturers of defense equipment in Japan.” I found several examples of Makino machines inside defense manufacturing ecosystems across Japan, Europe, and the US. They are used to make flight-critical structures and propulsion components for F-35 and Typhoon fighter jets, CH-47 and OH-1 helicopter engines, and gas turbines of Japanese destroyers.
Beyond defense, management is also targeting aerospace, energy, semiconductor, and medical markets, where customers need high-precision machining of difficult materials and are willing to pay up for productivity, accuracy, and process know-how. Key applications are aircraft engine parts, gas turbines, semiconductor equipment, and medical devices.
Makino’s opportunity in the emerging space economy deserves a separate post. The US satellite producer Astranis uses Makino MAG3.EX to machine full satellite panels in-house (video linked below). I’m also fairly confident that Makino machines are integrated into the supply chains of SpaceX and Blue Origin.
After the acquisition fiasco, management is under pressure to unlock Makino’s true potential. The “Corporate Value Enhancement” plan announced in May focuses on larger and more complex machines, pricing discipline, shorter lead times, higher-margin engineering and aftermarket services, dividends, and buybacks.
The plan is good, but I think it undersells the opportunity. I assume the company will achieve at least 7% revenue CAGR and reach 15% operating margin by 2030. That gets me to ¥21,500 per share or ~50% upside. At ~13 P/E, Makino looks too cheap for its strategic importance, technical depth, and end-market optionality. I took an initial position this week and will be watching for the buyback announcement and continued order build-up.